A Montreal study shows that, contrary to what was thought, depression, schizophrenia and bipolar disorder share common cerebral alterations, which could help develop new drugs.
A Montreal study shows that, contrary to what was thought, depression, schizophrenia and bipolar disorder share common cerebral alterations, which could help develop new drugs.